First Rounder: Jeremy Levin
Jeremy Levin is chairman and CEO of Ovid Therapeutics, formerly president and CEO of Teva Pharmaceutical Industries, and former member of the executive committee at Bristol-Myers Squibb, where he led that company's 'string of pearls' strategy. His conversation with Nature Biotechnology covers shifting his mindset from treating patients to business development, his youth in South Africa, and how his past influences his view of the 2016 US presidential election results.
More From 'Nature Biotechnology Podcast'
-
Apr265 months agoRachel Haurwitz is co-founder, president and CEO of Caribou Biosciences. In her discussion with Nature Biotechnology, she explains what drew her into the sciences, how her father's journalism caree...
-
Feb237 months agoStephen Quake is a professor in the department of bioengineering at Stanford University and a serial founder of biotech companies. His talk with Nature Biotechnology covers launching Fluidigm, bein...
-
Nov1710 months agoAnu Acharya is founder and CEO of Mapmygenome, a co-founder of Ocimum Biosolutions and a leading light for life science entrepreneurship in India. Her discussion with Nature Biotechnology covers th...
-
Sep2212 months agoNancy J Kelley, founder and chief executive of Nancy J Kelley + Associates, a consultancy creating and developing projects and institutions for science and medicine, touches on establishing the Eas...
-
Jul191 year agoDavid Baltimore, president emeritus of the California Institute of Technology, discusses his parents moving him from New York City to Great Neck, Long Island, as a child; his initial interest in an...
-
May261 year agoTom Maniatis is a founder of Kallyope, and head of the Maniatis lab at Columbia University. Among other things, he's founded several biotechs and authored a manual nicknamed 'the bible of cloning.'...
-
Mar102 years agoDaniel Cohen discusses the industrialization of genomic sequencing, his part in founding Millennium and why the conductor has the most difficult job in an orchestra.
-
Dec222 years agoNature Biotechnology talked to Wilson about his love of motocross racing, the triumphs and tribulation of gene therapy (including the Jesse Gelsinger tragedy), and the future of drug pricing.
-
Oct222 years agoNature Biotechnology spoke to Rutter about building out the labs at UCSF, sequencing the hepatitis C virus and his short stint in the Navy.
-
Greg Winter is the Master of Trinity College, Cambridge, and a serial entrepreneur, who co-founded Cambridge Antibody Technology. Much of his career was spent at the Medical Research Council, and h...